Related Experiment Videos
Hepatic tumors: contrast agent-enhancement patterns with pulse-inversion harmonic US.
1Department of Radiology and Institute of Radiation Medicine, Seoul National University Hospital, 28, Yongon-dong, Chongno-gu, Seoul 110-744, South Korea.
Radiology
|August 5, 2000
Summary
Pulse-inversion harmonic ultrasonography effectively differentiates hepatic hemangiomas from malignant tumors. This advanced imaging technique reveals characteristic enhancement patterns for accurate diagnosis of liver lesions.
Area of Science:
- Medical Imaging
- Hepatology
- Radiology
Background:
- Distinguishing benign hepatic hemangiomas from malignant liver lesions like metastases and hepatocellular carcinomas (HCCs) is crucial for patient management.
- Conventional ultrasonography (US) can be limited in characterizing focal liver lesions.
Purpose of the Study:
- To assess the diagnostic utility of pulse-inversion harmonic ultrasonography (PIH-US) with a microbubble contrast agent.
- To evaluate and compare contrast-enhancement patterns of hepatic hemangiomas, metastases, and HCCs using PIH-US.
Main Methods:
- Sixty-one hepatic lesions (20 hemangiomas, 33 metastases, 8 HCCs) were examined using PIH-US.
- A microbubble contrast agent (SH U 508A) was administered as a bolus, and dynamic imaging was performed for 5 minutes.
- Contrast-enhancement patterns, including peripheral, globular, rimlike, homogeneous, stippled, and centripetal fill-in, were analyzed.
Main Results:
- Hemangiomas predominantly showed peripheral, globular, or rimlike enhancement with centripetal fill-in (95%).
- Malignant lesions (metastases and HCCs) exhibited varied patterns including rimlike, homogeneous, stippled, or heterogeneous enhancement, with no centripetal fill-in observed.
- No enhancement was detected in 24% of metastases.
Conclusions:
- PIH-US with microbubble contrast agents demonstrates significant potential for the specific diagnosis of hepatic hemangiomas.
- Characteristic enhancement patterns observed with PIH-US aid in differentiating hemangiomas from malignant liver tumors.